198 related articles for article (PubMed ID: 29462945)
21. KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function.
Gala K; Li Q; Sinha A; Razavi P; Dorso M; Sanchez-Vega F; Chung YR; Hendrickson R; Hsieh JJ; Berger M; Schultz N; Pastore A; Abdel-Wahab O; Chandarlapaty S
Oncogene; 2018 Aug; 37(34):4692-4710. PubMed ID: 29755131
[TBL] [Abstract][Full Text] [Related]
22. The transcriptional co-activator NCOA6 promotes estrogen-induced GREB1 transcription by recruiting ERα and enhancing enhancer-promoter interactions.
Tong Z; Liu Y; Yu X; Martinez JD; Xu J
J Biol Chem; 2019 Dec; 294(51):19667-19682. PubMed ID: 31744881
[TBL] [Abstract][Full Text] [Related]
23. Widespread enhancer activation via ERα mediates estrogen response in vivo during uterine development.
Jefferson WN; Kinyamu HK; Wang T; Miranda AX; Padilla-Banks E; Suen AA; Williams CJ
Nucleic Acids Res; 2018 Jun; 46(11):5487-5503. PubMed ID: 29648668
[TBL] [Abstract][Full Text] [Related]
24. Effects of oestrogen on long noncoding RNA expression in oestrogen receptor alpha-positive ovarian cancer cells.
Qiu J; Ye L; Ding J; Feng W; Zhang Y; Lv T; Wang J; Hua K
J Steroid Biochem Mol Biol; 2014 May; 141():60-70. PubMed ID: 24380700
[TBL] [Abstract][Full Text] [Related]
25. Ligand dependent gene regulation by transient ERα clustered enhancers.
Saravanan B; Soota D; Islam Z; Majumdar S; Mann R; Meel S; Farooq U; Walavalkar K; Gayen S; Singh AK; Hannenhalli S; Notani D
PLoS Genet; 2020 Jan; 16(1):e1008516. PubMed ID: 31905229
[TBL] [Abstract][Full Text] [Related]
26. A Non-canonical Role of YAP/TEAD Is Required for Activation of Estrogen-Regulated Enhancers in Breast Cancer.
Zhu C; Li L; Zhang Z; Bi M; Wang H; Su W; Hernandez K; Liu P; Chen J; Chen M; Huang TH; Chen L; Liu Z
Mol Cell; 2019 Aug; 75(4):791-806.e8. PubMed ID: 31303470
[TBL] [Abstract][Full Text] [Related]
27. Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha.
Frietze S; O'Geen H; Littlepage LE; Simion C; Sweeney CA; Farnham PJ; Krig SR
BMC Genomics; 2014 Jun; 15(1):520. PubMed ID: 24962896
[TBL] [Abstract][Full Text] [Related]
28. Distinct Roles for BET Family Members in Estrogen Receptor α Enhancer Function and Gene Regulation in Breast Cancer Cells.
Murakami S; Li R; Nagari A; Chae M; Camacho CV; Kraus WL
Mol Cancer Res; 2019 Dec; 17(12):2356-2368. PubMed ID: 31551256
[TBL] [Abstract][Full Text] [Related]
29. Gene expression signature of estrogen receptor alpha status in breast cancer.
Abba MC; Hu Y; Sun H; Drake JA; Gaddis S; Baggerly K; Sahin A; Aldaz CM
BMC Genomics; 2005 Mar; 6():37. PubMed ID: 15762987
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide activity of unliganded estrogen receptor-α in breast cancer cells.
Caizzi L; Ferrero G; Cutrupi S; Cordero F; Ballaré C; Miano V; Reineri S; Ricci L; Friard O; Testori A; Corà D; Caselle M; Di Croce L; De Bortoli M
Proc Natl Acad Sci U S A; 2014 Apr; 111(13):4892-7. PubMed ID: 24639548
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA MIAT is estrogen-responsive and promotes estrogen-induced proliferation in ER-positive breast cancer cells.
Li Y; Jiang B; Wu X; Huang Q; Chen W; Zhu H; Qu X; Xie L; Ma X; Huang G
Biochem Biophys Res Commun; 2018 Sep; 503(1):45-50. PubMed ID: 29792859
[TBL] [Abstract][Full Text] [Related]
32. DSCAM-AS1 regulates the G
Sun W; Li AQ; Zhou P; Jiang YZ; Jin X; Liu YR; Guo YJ; Yang WT; Shao ZM; Xu XE
Cancer Med; 2018 Dec; 7(12):6137-6146. PubMed ID: 30430768
[TBL] [Abstract][Full Text] [Related]
33. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
[TBL] [Abstract][Full Text] [Related]
34. Classification of different types of estrogen receptor alpha binding sites in MCF-7 cells.
Bojcsuk D; Bálint BL
J Biotechnol; 2019 Jun; 299():13-20. PubMed ID: 31039369
[TBL] [Abstract][Full Text] [Related]
35. The clinical significance of circulating DSCAM-AS1 in patients with ER-positive breast cancer and construction of its competitive endogenous RNA network.
Moradi MT; Fallahi H; Rahimi Z
Mol Biol Rep; 2020 Oct; 47(10):7685-7697. PubMed ID: 33040318
[TBL] [Abstract][Full Text] [Related]
36. Dependence receptor UNC5A restricts luminal to basal breast cancer plasticity and metastasis.
Padua MB; Bhat-Nakshatri P; Anjanappa M; Prasad MS; Hao Y; Rao X; Liu S; Wan J; Liu Y; McElyea K; Jacobsen M; Sandusky G; Althouse S; Perkins S; Nakshatri H
Breast Cancer Res; 2018 May; 20(1):35. PubMed ID: 29720215
[TBL] [Abstract][Full Text] [Related]
37. DSCAM-AS1-Driven Proliferation of Breast Cancer Cells Involves Regulation of Alternative Exon Splicing and 3'-End Usage.
Elhasnaoui J; Miano V; Ferrero G; Doria E; Leon AE; Fabricio ASC; Annaratone L; Castellano I; Sapino A; De Bortoli M
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32503257
[No Abstract] [Full Text] [Related]
38. H19 lncRNA mediates 17β-estradiol-induced cell proliferation in MCF-7 breast cancer cells.
Sun H; Wang G; Peng Y; Zeng Y; Zhu QN; Li TL; Cai JQ; Zhou HH; Zhu YS
Oncol Rep; 2015 Jun; 33(6):3045-52. PubMed ID: 25846769
[TBL] [Abstract][Full Text] [Related]
39. H4K12ac is regulated by estrogen receptor-alpha and is associated with BRD4 function and inducible transcription.
Nagarajan S; Benito E; Fischer A; Johnsen SA
Oncotarget; 2015 Mar; 6(9):7305-17. PubMed ID: 25788266
[TBL] [Abstract][Full Text] [Related]
40. The Estrogen Receptor α Signaling Pathway Controls Alternative Splicing in the Absence of Ligands in Breast Cancer Cells.
Elhasnaoui J; Ferrero G; Miano V; Cutrupi S; De Bortoli M
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
